65 related articles for article (PubMed ID: 34433910)
1. SIRT1 Inhibition-Induced Mitochondrial Damage Promotes GSDME-Dependent Pyroptosis in Hepatocellular Carcinoma Cells.
Liu D; Liu J; Liu K; Hu Y; Feng J; Bu Y; Wang Q
Mol Biotechnol; 2023 Dec; ():. PubMed ID: 38044396
[TBL] [Abstract][Full Text] [Related]
2. The Multi-Faceted Consequences of NRF2 Activation throughout Carcinogenesis.
Occhiuto CJ; Moerland JA; Leal AS; Gallo KA; Liby KT
Mol Cells; 2023 Mar; 46(3):176-186. PubMed ID: 36994476
[TBL] [Abstract][Full Text] [Related]
3. Sirt1 deficiency upregulates glutathione metabolism to prevent hepatocellular carcinoma initiation in mice.
Qiu P; Hou W; Wang H; Lei KKW; Wang S; Chen W; Pardeshi LA; Prothro K; Shukla Y; Su SSM; Schrump DS; Chen Q; Deng CX; Xu X; Wang R
Oncogene; 2021 Oct; 40(41):6023-6033. PubMed ID: 34433910
[TBL] [Abstract][Full Text] [Related]
4. Glutathione metabolism in hepatomous liver of rats treated with diethylnitrosamine.
Marinho HS; Baptista M; Pinto RE
Biochim Biophys Acta; 1997 Apr; 1360(2):157-68. PubMed ID: 9128181
[TBL] [Abstract][Full Text] [Related]
5. Hepatic loss of miR-122 predisposes mice to hepatobiliary cyst and hepatocellular carcinoma upon diethylnitrosamine exposure.
Hsu SH; Wang B; Kutay H; Bid H; Shreve J; Zhang X; Costinean S; Bratasz A; Houghton P; Ghoshal K
Am J Pathol; 2013 Dec; 183(6):1719-1730. PubMed ID: 24113455
[TBL] [Abstract][Full Text] [Related]
6. Abberent expression of NOR1 protein in tumor associated macrophages contributes to the development of DEN-induced hepatocellular carcinoma.
Chen S; Zheng P; Wang W; Yi M; Chen P; Cai J; Li J; Peng Q; Ban Y; Zhou Y; Zeng Z; Li X; Xiong W; Li G; Xiang B
J Cell Physiol; 2018 Jun; 233(6):5002-5013. PubMed ID: 29227538
[TBL] [Abstract][Full Text] [Related]
7. Hepatic leptin receptor expression can partially compensate for IL-6Rα deficiency in DEN-induced hepatocellular carcinoma.
Mittenbühler MJ; Sprenger HG; Gruber S; Wunderlich CM; Kern L; Brüning JC; Wunderlich FT
Mol Metab; 2018 Nov; 17():122-133. PubMed ID: 30224299
[TBL] [Abstract][Full Text] [Related]
8. Modulation of antioxidant enzymes, SIRT1 and NF-κB by resveratrol and nicotinamide in alcohol-aflatoxin B1-induced hepatocellular carcinoma.
Rawat D; Chhonker SK; Naik RA; Koiri RK
J Biochem Mol Toxicol; 2021 Jan; 35(1):e22625. PubMed ID: 32894639
[TBL] [Abstract][Full Text] [Related]
9. The Role of SIRT1 on DNA Damage Response and Epigenetic Alterations in Cancer.
Alves-Fernandes DK; Jasiulionis MG
Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261609
[TBL] [Abstract][Full Text] [Related]
10. From NASH to HCC: current concepts and future challenges.
Anstee QM; Reeves HL; Kotsiliti E; Govaere O; Heikenwalder M
Nat Rev Gastroenterol Hepatol; 2019 Jul; 16(7):411-428. PubMed ID: 31028350
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular Carcinoma.
Villanueva A
N Engl J Med; 2019 Apr; 380(15):1450-1462. PubMed ID: 30970190
[No Abstract] [Full Text] [Related]
12. N-acetylcysteine decreases malignant characteristics of glioblastoma cells by inhibiting Notch2 signaling.
Deng J; Liu AD; Hou GQ; Zhang X; Ren K; Chen XZ; Li SSC; Wu YS; Cao X
J Exp Clin Cancer Res; 2019 Jan; 38(1):2. PubMed ID: 30606241
[TBL] [Abstract][Full Text] [Related]
13. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Bray F; Ferlay J; Soerjomataram I; Siegel RL; Torre LA; Jemal A
CA Cancer J Clin; 2018 Nov; 68(6):394-424. PubMed ID: 30207593
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
